Dr. Martens plc (the 'Company')
Director/PDMR Shareholding
Notification of Transactions by Directors/Persons Discharging Managerial Responsibility
The Company announces that it has been notified that Lynne Weedall, Senior Independent Director and PDMR, purchased 25,000 ordinary shares of 1 pence each in the Company ('Ordinary Shares') on 27 August 2024 at a price of £0.7441448 per Ordinary Share.
The relevant notification, set out below, is provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||||||
| a) | Name | Lynne Weedall | ||||||
| 2 | Reason for the notification | |||||||
| a) | Position/status | PDMR (Senior Independent Director) | ||||||
| b) | Initial notification/Amendment | Initial notification | ||||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
| a) | Name | Dr. Martens plc | ||||||
| b) | LEI | 213800QPT8YM6NQZPH28 | ||||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of GBP 0.01
| ||||||
| b) | Nature of the transaction | Purchase of Ordinary Shares | ||||||
| c) | Price(s) and volume(s) |
| ||||||
| d) | Aggregated information
|
Single transaction | ||||||
| e) | Date of the transaction | 27 August 2024 | ||||||
| f) | Place of the transaction | London Stock Exchange (XLON) | ||||||
For further information please contact:
Bethany Barnes
Director of Investor Relations
bethany.barnes@drmartens.com
+4478 2518 7465
Paul Rolling
Assistant Company Secretary
paul.rolling@drmartens.com
+4475 8424 3562
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.